U.S. Physical Therapy - USPH Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings or view top-rated stocks.

2 equities research analysts have issued 1 year price targets for U.S. Physical Therapy's stock. Their USPH share price forecasts range from $120.00 to $123.00. On average, they predict the company's stock price to reach $121.50 in the next year. This suggests a possible upside of 45.5% from the stock's current price.
View analysts price targets for USPH or view top-rated stocks among Wall Street analysts.

U.S. Physical Therapy's stock was trading at $95.55 at the beginning of 2022. Since then, USPH shares have decreased by 12.6% and is now trading at $83.49.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our USPH earnings forecast.

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its earnings results on Thursday, August, 4th. The company reported $0.90 EPS for the quarter, missing the consensus estimate of $0.93 by $0.03. The business earned $140.70 million during the quarter, compared to analysts' expectations of $143.01 million. U.S. Physical Therapy had a net margin of 7.62% and a trailing twelve-month return on equity of 14.22%. The firm's quarterly revenue was up 10.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.96 EPS.

U.S. Physical Therapy declared a quarterly dividend on Thursday, August 4th. Stockholders of record on Thursday, August 18th will be given a dividend of $0.41 per share on Friday, September 16th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date is Wednesday, August 17th.
Read our dividend analysis for USPH.

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.64 per share and currently has a dividend yield of 1.87%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 55.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, USPH will have a dividend payout ratio of 54.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

U.S. Physical Therapy issued an update on its FY 2022 earnings guidance on Thursday, August, 18th. The company provided EPS guidance of $2.65-$2.75 for the period. The company issued revenue guidance of -.

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (11.61%), Price T Rowe Associates Inc. MD (9.57%), Copeland Capital Management LLC (3.99%), State Street Corp (3.56%), Boston Trust Walden Corp (3.50%) and Riverbridge Partners LLC (3.31%). Insiders that own company stock include Anne Motsenbocker, Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Christopher J Reading, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner, Regg E Swanson and Richard Binstein.
View institutional ownership trends.

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of USPH stock can currently be purchased for approximately $83.49.

U.S. Physical Therapy (NYSE:USPH) has a market capitalization of $1.09 billion and generates $495.02 million in revenue each year. The company earns $40.83 million in net income (profit) each year or $2.93 on an earnings per share basis.

The company employs 5,500 workers across the globe.

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The official website for the company is www.usph.com. The company can be reached via phone at (713) 297-7000, via email at lmcafee@usph.com, or via fax at 713-297-7090.